Keith Humphreys

All CHP/PCOR People All Faculty
khumphreys

Keith Humphreys, PhD

  • Esther Ting Memorial Professor
  • Stanford Health Policy Associate
Stanford School of Medicine 401 N. Quarry Road (MC:5717) Stanford, CA 94305-5717
(650) 723-9067 (voice)
(650) 617-2736 (fax)

Biography

Keith Humphreys is the Esther Ting Memorial Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University.  He is also a Senior Research Career Scientist at the VA Health Services Research Center in Palo Alto and an Honorary Professor of Psychiatry at the Institute of Psychiatry, King's College, London.  His research addresses the prevention and treatment of addictive disorders, the formation of public policy and the extent to which subjects in medical research differ from patients seen in everyday clinical practice.

For his work in the multinational humanitarian effort to rebuild the psychiatric care system of Iraq and in the national redesign of the VA health system's mental health services for Iraq war veterans, he won the 2009 American Psychological Association Award for Distinguished Contribution to the Public Interest.  He and the authors of "Drug Policy and the Public Good" won the 2010 British Medical Association's Award for Public Health Book of the Year.

Dr. Humphreys has been extensively involved in the formation of public policy, having testified to Congress on multiple occasions, and having served as a member of the White House Commission on Drug Free Communities, the VA National Mental Health Task Force, and the National Advisory Council of the U.S. Substance Abuse and Mental Health Services Administration.  During the Obama Administration, he spent a sabbatical year as Senior Policy Advisor at the White House Office of National Drug Control Policy. He has also testified on numerous occasions in the U.K. Parliament and advises multiple government agencies in the U.K.  He created and co-directs the Stanford Network on Addiction Policy, which brings scientists and policy makers together to improve public policies regarding addictive substances.  He is also leading the Stanford-Lancet Commission on the North American Opioid Crisis.

In The News

Encina Hall and its front lawn
News

Why the massive black market trade in cigarettes affects you even if you don't smoke

A National Academy of Sciences committee meets this week to study a large, growing and little-understood black market in drugs. But rather than cocaine, heroin and methamphetamine, the committee members will be discussing tobacco cigarettes. The global black market in tobacco is estimated to supply 11.6% of the world’s consumption, a startling 650 billion cigarettes a year. And there are two components to this market that have drawn the particular scrutiny of law enforcement: fake cigarettes and tax avoidance.
Encina Hall and its front lawn
Commentary

You're Never Too Old to Be Studied

When older patients seek health care, they are unwittingly enrolling in an experiment: Will medical procedures that have been proved effective mainly on the young also help the elderly?
Encina Hall and its front lawn
Commentary

Growth in Drug Treatment Has Led to More Innovation

Insurance coverage for addiction treatment has been expanded more in the past five months than in the preceding five decades. Contrary to the common complaint that nothing is changing in the “war on drugs”, the U.S. has never been closer to providing universal addiction treatment on demand.